Contact Information
![](https://fhs.um.edu.mo/wp-content/uploads/2019/11/Lijun-DI-819x1024.jpg)
Title
Associate Professor
Office
(Office) E12-4009
/ (Lab) N22-4009a
Phone
(Office) +853 8822 4497
/ (Lab) +853 8822 2939
Fax
+853 8822 2314
Email
Consultation Hours
Tue, Fri 09:00 – 10:00
Research Team
Name | Position | Office | Phone | |
---|---|---|---|---|
Dr. Li WANG | Senior Instructor (Lab Representative) | E12-4024 | +853 8822 4498 | liwang@um.edu.mo |
Junyi LI | PhD Student | |||
Dongliang ZHU | PhD Student | N22-4011 | +853 8822 4291 | |
Ping TANG | PhD Student | N22-4011 | +853 8822 4291 | |
Jiajia LI | PhD Student | N22-4010 | +853 8822 4260 | |
Lifen WANG | PhD Student | N22-4010 | +853 8822 4260 | |
Hongxia XU | PhD Student | N22-4011 | +853 8822 4291 | |
Tianyu LIU | PhD Student | N22-4010 | +853 8822 4260 |
89
Education | |
PhD | Biochemistry and molecular biology, Peking Union Medical College, Tsinghua University, Beijing, China (2006) |
MSc | Genetics, Institute of Hydrobiology, Chinese Academy of Sciences, Wuhan, China (2003) |
BSc | Biology, School of life sciences, University of Inner Mongolia, Huhehaote, China (2000) |
Positions | |
2018 – Present | Associate Professor, Faculty of Health Sciences, University of Macau |
2013 – 2018 | Assistant Professor, Faculty of Health Sciences, University of Macau |
2007 – 2012 | Visiting Fellow and Research Fellow, National Cancer Institute, National Institutes of Health, USA |
2006 – 2007 | Postdoc Fellow, Biochemistry Department, University of Texas, Health Science Center at San Antonio, USA |
Research Interests |
Dr. Di’s group works on diseases including cancer and metabolic disorders in gene function and energy metabolism perspectives using both the in vivo and in vitro models. By applying biochemistry, molecular biology, histology, transgenic mice, bioinformatics approaches and focusing on a few key factors, our research illustrated several novel regulatory mechanisms that play important roles in promoting cancer progression, cancer metabolism and microenvironment regulation and increasing chemo drug resistance etc.; and some regulatory axes regulating obesity induced inflammation and its associated insulin resistance and diabetes etc. Our goal is to identify some novel biomarkers or potential therapeutic targets that are employable to a subgroup of the patients based on a deeper understanding of the heterogeneity of the disease mechanistically. |
Representative Publications |
|
Awards | |
2020 | Recipient of FDCT research excellence for Graduate Student (Awarded to Dr. Li jingjing) |
2019 | Recipient of FDCT research excellence for Graduate students (Awarded to Dr. Hao Dapeng) |
2017 | Recipient of Outstanding Academic Staff (Awarded to Lijun Di) |
2017 | Recipient of 1st prize for presentation of 4th Macau Symposium of Biomedical Sciences (Awarded to PhD student Hao Dapeng) |
2016 | Recipient for 3rd prize for presentation on 2016 national conference of biochemistry and molecular biology (Awarded to Di Lijun) |
2016 | 2nd prize for presentation on 5th international oncology conference in Guangzhou (Awarded to PhD student Li Peipei) |
2016 | Recipients of EMSO Asia travel award (Award to Di Lijun and PhD student Li jingjing) |
2015 | Selected as 1st prize for presentation of 2th Macau symposium of Biomedical Sciences (Award to PhD student Hao Dapeng) |
2011 | Recipient of The Fellows Award for Research Excellence (FARE) Award from CCR/NCI (Award to Di Lijun) |
2010 | Selected as one of TOP 10 most significant advances of CCR/NCI, USA |
Professional Activities |
Serve as reviewer for journals including International Journal of biological sciences, Experimental Cell Research, Endocrinology, Hereditary cancer in clinical practice, LSA, Molecular carcinogenesis etc. |
Associate Editor of Journal of Ovarian Research (Biomedcentral) |
External reviewer for Health and Medical Research Fund of Hong Kong |
External reviewer for Barth syndrome foundation |
Reviewer for National Science foundation (Young) |